HOME >> BIOLOGY >> NEWS
JCI table of contents, March 9, 2006

, which develops human-like asthma symptoms including airway hyperresponsiveness (AHR), mucus production, production of proinflammatory proteins called cytokines, and increased numbers of immune cells called eosinophils and Th2 cells in the lung. The researchers injected these asthmatic mice with an antibody that stimulates the activity of an immune protein called CD137. A single injection of this "agonistic" anti-CD137 antibody was able to inhibit AHR, eosinophilic airway inflammation, and Th2 cytokine production for the complete observation period of almost 7 weeks. The lasting effects of this treatment suggest that this type of antibody therapy may be used in the future to treat the recurring symptoms of allergy in humans. Specifically, the authors suggest that strategies aimed at stimulation of CD137, which has previously been shown to induce tumor rejection, may represent a clinical target for allergic inflammatory responses and other disorders characterized by inappropriate T cell activation.

TITLE: CD137-mediated immunotherapy for allergic asthma

AUTHOR CONTACT: Gesine Hansen
Medizinische Hochschule
Hannover, Hannover, Germany
Phone: 0049-511-532-9138; Fax: 0049-511-532-9125; E-mail: hansen.gesine@mh-hannover.de
View the PDF of this article at: https://www.the-jci.org/article.php?id=23792


'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
9-Mar-2006


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2019)... CHICAGO (PRWEB) , ... August 22, 2019 , ... ... by rebranding to Planet121 following their acquisition in June of 2018. Along with ... logo and communications. , “Our goal was to create a cohesive brand ...
(Date:8/21/2019)... (PRWEB) , ... August 20, 2019 , ... ... experience for the second time since BioInformatics first fielded the survey in 2016. ... Life Science Customer Experience , from BioInformatics, part of Science and Medicine Group. ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... what? As serialization mandates become increasingly complex, and aggregation becomes fully applied in ... software is the best long-term solution. , Until now, most regulations?including the Drug ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ROANOKE, Va. (PRWEB) , ... June 11, 2019 ... ... for microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced ... in virtual care. , Mytonomy recently deployed its virtual care platform ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study ... stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying their ... mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. This ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms ... cancer demand breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric ... with engineered T cell receptors known as “CARs”. The CAR enables the final product ...
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance Seminars today ... 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is always selected ... training will kick off with a compendial treatment of Data Integrity fundamentals. After ...
Breaking Biology Technology:
Cached News: